In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Study Groups

ESC Working Group on Myocardial and Pericardial Diseases

At the annual assembly in Barcelona in 2009 we announced our intention to create study groups examining topics relevant to the core themes of the Working Group.
We are pleased to announce the following Study groups have been created.
  • Genetic cardiomyopathies
  • Inflammatory and infective heart muscle disease
  • Pericardial diseases/interventional pericardiology

Each study group aims to promote and support the activity and interests of the Working Group nucleus and membership.

Three topics have been identified to launch those study groups. Each topic will be deliverable within a maximum of two years.

The nucleus has also nominated three theme coordinators to administer this new structure (see figure below). They will be responsible for the oversight of the study groups and liaison between the study groups and the nucleus. 
Theme coordinators are appointed for two years.


 Study groups structure

Role of Study Groups leaders:

Each study group will work in partnership with their theme coordinator from the nucleus.

Each study group leader will serve for one year, with the possibility of extension for one additional year.

In consultation with their theme coordinator, each study group leader may nominate up to six individuals (the “study group”) to assist them in the delivery of their allocated topic. These individuals do not necessarily need to be Working Group members but must have appropriate skills and knowledge relevant to the study group topic.
The nucleus also aims to encourage the involvement of young investigators as well as more established experts. Membership of the study groups will be scrutinised and approved by the nucleus.

Each study group leader will be expected to produce a report and will have the opportunity to report their group’s progress at the Annual General Meeting.

Appointment of study group leaders:

Study group leaders MUST fulfil the following criteria:

Study group leaders MUST fulfil the following criteria:

  • Membership of the Working Group 
  • Demonstrable track record (clinical and/or scientific) in the specific topic
  • Ideally not from same institution as an existing nucleus member

All Working Group members are invited to submit their candidacy before May 20th using a web-based standard submission form.

Applications for study group leaders will be assessed by the full nucleus and the successful candidates will be announced within three weeks of the closing date.

Only one individual can be selected for each study group lead.

Candidates not selected for leadership can still be considered as members of each study group if they meet criteria set by the nucleus.

In addition to the three topics selected, we would like to receive your ideas for future topics. You can send your suggestions to the Vice-Chairman of the Working Group, Dr Philippe Charron.